Skip to content

Metabolic Cluster Analysis in Septic Shock Patients

Metabolic Cluster Analysis in Septic Shock Patients Undergoing Hemodynamic Resuscitation. A Multicenter Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06500156
Acronym
ACMEcat
Enrollment
120
Registered
2024-07-15
Start date
2024-05-01
Completion date
2026-10-31
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic Shock

Keywords

septic shock, hemodynamic resuscitation, cardiovascular monitoring

Brief summary

Observational study including septic shock patients within 24 hours of ICU admission, monitored with a cardiac output estimation system, with ongoing resuscitation. Hemodynamic and metabolic parameters before and after a fluid challenge (FC) will be measured.

Interventions

OTHERFluid challenge

Rapid infusion (\< 15 minutes) of a fluid bolus of crystalloids (200 to 500cc)

Sponsors

Corporacion Parc Tauli
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Septic shock patients within the first 24 hours of ICU admission, and selected by the attending physician for performing a fluid challenge (FC) due to suspected tissue hypoperfusion (elevated lactate and/or ScvO2 \< 70%).

Exclusion criteria

* Age under 18 years old * Uncontrolled hemodynamic instability, defined as the need for significant changes in vasopressor support (\> 10% from baseline dose) within the 15-minute period prior to, and/or during the administration of fluids. * Patients receiving continuous renal replacement therapies, since the CO values obtained from the thermodilution techniques might be potentially affected.

Design outcomes

Primary

MeasureTime frameDescription
VO2-response30 minutesPercentage increase in VO2 as results of the fluid challenge

Secondary

MeasureTime frameDescription
Organ failure4 daysAssessment of the SOFA score at day 1, 2 and 4
Mortality28 daysMortality within the first 28 days

Countries

Spain

Contacts

Primary ContactJaume Mesquida, MD
jaume.mesquida@gmail.com+34937231010
Backup ContactFerran Oller, MD
ferranollersanchez@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026